AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List
The Philadelphia Inquirer • Sat Apr 11 2026
AscellaHealth has been named to the Financial Times’ list of the Americas’ Fastest Growing Companies 2026 for the fourth consecutive year. The award is presented by the Financial Times in collaboration with Statista Inc., a world-leading provider of market and consumer data.
“This recognition is about far more than our company’s growth. It underscores AscellaHealth’s unwavering commitment to expanding access to life-changing therapies and the impact we are having for individuals with complex, chronic conditions and rare diseases,” says Dea Belazi, CEO of AscellaHealth. “Our momentum is driven by a clear purpose—to transform the lives of patients and their families—while scaling globally with the right strategy, innovation, and expertise. Through strategic expansion and acquisitions, we continue to strengthen our market position and enhance the capabilities we deliver to partners and patients worldwide.”
The Americas’ Fastest Growing Companies 2026 ranking highlights firms with the strongest revenue growth from 2021 to 2024. Eligible companies must be independent, headquartered in the Americas, and demonstrate primarily organic growth, with revenue of at least US$100,000 in 2021 and US$1.5million in 2024.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.